Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 9.58%45.85B | 9.58%45.85B | 26.47%50.31B | 3.34%52.01B | 1.48%47.45B | -12.33%41.84B | -12.33%41.84B | -15.14%39.78B | 7.64%50.33B | -26.15%46.76B |
-Cash and cash equivalents | 10.57%45.4B | 10.57%45.4B | 25.21%49.33B | 4.18%51.16B | 2.73%46.95B | -11.94%41.06B | -11.94%41.06B | -13.76%39.4B | 7.73%49.1B | -26.63%45.7B |
-Money market investments | -42.53%451M | -42.53%451M | 155.43%981.6M | -30.05%859.6M | -52.70%500.1M | -28.81%784.7M | -28.81%784.7M | -67.88%384.3M | 3.99%1.23B | 2.52%1.06B |
Receivables | -80.67%41.1M | -80.67%41.1M | 139.97%354.2M | -55.16%193.4M | -91.05%116.4M | -87.48%212.6M | -87.48%212.6M | -95.20%147.6M | -81.21%431.3M | -40.75%1.3B |
-Other receivables | -80.67%41.1M | -80.67%41.1M | 139.97%354.2M | -55.16%193.4M | -91.05%116.4M | -87.48%212.6M | -87.48%212.6M | -95.20%147.6M | -81.21%431.3M | -40.75%1.3B |
Net loan | -8.88%43.22B | -8.88%43.22B | -3.77%41.76B | -3.28%41.96B | 11.79%47.17B | 10.98%47.42B | 10.98%47.42B | -1.01%43.39B | 5.69%43.38B | 7.98%42.19B |
-Gross loan | -8.88%43.39B | -8.88%43.39B | -3.73%41.95B | -3.24%42.14B | 11.74%47.34B | 11.01%47.62B | 11.01%47.62B | -0.94%43.58B | 5.70%43.55B | 8.01%42.37B |
-Allowance for loans and lease losses | -8.74%175.5M | -8.74%175.5M | 5.80%193.3M | 5.46%179.5M | -0.62%175.8M | 19.37%192.3M | 19.37%192.3M | 18.33%182.7M | 10.02%170.2M | 16.38%176.9M |
Securities and investments | 4.03%51.3B | 4.03%51.3B | 3.57%51.02B | -1.21%49.66B | -0.42%49.14B | -4.86%49.31B | -4.86%49.31B | -5.68%49.26B | -8.82%50.27B | -15.05%49.34B |
-Trading securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%100K | -75.00%100K | -75.00%100K |
-Available for sale securities | --25.15B | --25.15B | 19.13%24.06B | 22.89%23.09B | 16.65%22.1B | ---- | ---- | -6.84%20.2B | -37.19%18.79B | -39.80%18.94B |
-Held to maturity securities | -41.06%15.45B | -41.06%15.45B | -14.66%17.18B | -14.16%17.75B | -9.54%18.62B | 4.74%26.22B | 4.74%26.22B | -2.35%20.13B | 33.30%20.68B | 27.53%20.59B |
-Short term investments | -53.69%10.69B | -53.69%10.69B | 9.46%9.78B | -18.36%8.82B | -14.24%8.42B | -13.52%23.09B | -13.52%23.09B | -10.05%8.94B | 11.36%10.8B | -6.33%9.82B |
Net PPE | -2.37%490.3M | -2.37%490.3M | 3.29%480.3M | 1.56%481M | 1.35%488M | 0.34%502.2M | 0.34%502.2M | -0.90%465M | -0.63%473.6M | -0.93%481.5M |
-Gross PPE | 0.00%1.33B | 0.00%1.33B | ---- | ---- | ---- | 6.49%1.33B | 6.49%1.33B | ---- | ---- | ---- |
-Accumulated depreciation | -1.44%-840.8M | -1.44%-840.8M | ---- | ---- | ---- | -10.59%-828.9M | -10.59%-828.9M | ---- | ---- | ---- |
Goodwill and other intangible assets | -1.05%694.9M | -1.05%694.9M | 2.17%707.8M | -0.20%697.4M | 0.35%697.5M | 1.59%702.3M | 1.59%702.3M | 2.03%692.8M | 1.28%698.8M | -0.98%695.1M |
-Goodwill | -1.05%694.9M | -1.05%694.9M | 2.17%707.8M | -0.20%697.4M | 0.35%697.5M | 1.59%702.3M | 1.59%702.3M | 2.03%692.8M | 1.28%698.8M | -0.98%695.1M |
Other assets | 29.03%13.92B | 29.03%13.92B | -11.63%11.13B | 5.61%11.79B | 6.97%11.05B | 9.47%10.79B | 9.47%10.79B | -0.65%12.59B | -1.94%11.17B | 18.79%10.33B |
Total assets | 3.13%155.51B | 3.13%155.51B | 6.44%155.75B | 0.03%156.8B | 3.31%156.11B | -2.74%150.78B | -2.74%150.78B | -8.45%146.33B | -0.66%156.75B | -12.43%151.11B |
Liabilities | ||||||||||
Total deposits | 5.44%122.48B | 5.44%122.48B | 10.00%121.18B | 8.65%122.99B | 8.98%123.94B | -6.27%116.16B | -6.27%116.16B | -14.30%110.17B | -15.31%113.2B | -23.99%113.73B |
Federal funds purchased and securities sold under agreement to repurchase | -31.56%2.62B | -31.56%2.62B | -51.81%2.93B | -70.62%3.04B | -35.84%3.11B | 55.44%3.83B | 55.44%3.83B | 23.53%6.09B | 769.31%10.33B | 1,370.20%4.85B |
Long term debt and capital lease obligation | -0.25%13.37B | -0.25%13.37B | 1.33%13.8B | -20.57%13.64B | -17.69%13.34B | 8.26%13.41B | 8.26%13.41B | 24.62%13.62B | 116.97%17.17B | 131.32%16.21B |
-Long term debt | -0.25%13.37B | -0.25%13.37B | 1.33%13.8B | -20.57%13.64B | -17.69%13.34B | 8.26%13.41B | 8.26%13.41B | 24.62%13.62B | 116.97%17.17B | 131.32%16.21B |
Other liabilities | -22.63%4.24B | -22.63%4.24B | 10.31%5.09B | 1.51%4.47B | -23.65%3.62B | 9.74%5.49B | 9.74%5.49B | 4.66%4.61B | 11.91%4.41B | 13.06%4.74B |
Total liabilities | 2.76%142.72B | 2.76%142.72B | 6.34%143B | -0.67%144.14B | 3.22%144.01B | -3.40%138.89B | -3.40%138.89B | -9.63%134.48B | -1.09%145.12B | -13.42%139.52B |
Shareholders'equity | ||||||||||
Share capital | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B |
-common stock | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M | 0.00%408.6M |
-Preferred stock | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M | 0.00%884.9M |
Paid-in capital | 1.56%1.03B | 1.56%1.03B | 1.51%1.01B | 1.72%996.9M | 1.97%983.5M | 2.65%1.01B | 2.65%1.01B | 3.06%993.1M | 3.04%980M | 3.52%964.5M |
Retained earnings | 9.70%15.61B | 9.70%15.61B | 7.22%15.31B | 6.29%15.02B | 2.30%14.28B | 3.15%14.23B | 3.15%14.23B | 3.44%14.28B | 3.99%14.13B | 4.61%13.96B |
Less: Treasury stock | 23.71%4.33B | 23.71%4.33B | 21.70%4.09B | 12.68%3.79B | 8.41%3.54B | 7.83%3.5B | 7.83%3.5B | 3.37%3.36B | 3.36%3.36B | 0.35%3.26B |
Gains losses not affecting retained earnings | 28.46%-814M | 28.46%-814M | 42.83%-779.5M | 38.47%-865M | 32.84%-917.6M | 27.49%-1.14B | 27.49%-1.14B | 23.62%-1.36B | 6.93%-1.41B | -50.63%-1.37B |
Total stockholders'equity | 7.48%12.79B | 7.48%12.79B | 7.61%12.75B | 8.77%12.66B | 4.44%12.1B | 5.67%11.9B | 5.67%11.9B | 7.40%11.85B | 5.11%11.64B | 1.56%11.59B |
Total equity | 7.48%12.79B | 7.48%12.79B | 7.61%12.75B | 8.77%12.66B | 4.44%12.1B | 5.67%11.9B | 5.67%11.9B | 7.40%11.85B | 5.11%11.64B | 1.56%11.59B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |